[1]周思琪,程雨馨,张兴彩.基于网络药理学和分子对接技术探讨冬虫夏草治疗特发性肺间质纤维化的作用机制[J].西部中医药,2024,37(05):90-96.[doi:10.12174/j.issn.2096-9600.2024.05.17]
　ZHOU Siqi,CHENG Yuxin,ZHANG Xingcai.The Mechanism of Action of Dongchongxiacao in the Treatment of Idiopathic Pulmonary Fibrosis based on Network Pharmacology and Molecular Docking Technology[J].Western Journal of Traditional Chinese Medicine,2024,37(05):90-96.[doi:10.12174/j.issn.2096-9600.2024.05.17]
点击复制

基于网络药理学和分子对接技术探讨冬虫夏草治疗特发性肺间质纤维化的作用机制
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
37
期数:
2024年05期
页码:
90-96
栏目:
二次研究
出版日期:
2024-05-15

文章信息/Info

Title:
The Mechanism of Action of Dongchongxiacao in the Treatment of Idiopathic Pulmonary Fibrosis based on Network Pharmacology and Molecular Docking Technology
作者:
周思琪1, 程雨馨1, 张兴彩2
1.山东中医药大学，山东 济南 250014
2.山东中医药大学附属医院，山东 济南 250014
Author(s):
ZHOU Siqi1, CHENG Yuxin1, ZHANG Xingcai2
1.Shandong University of Traditional Chinese Medicine, Jinan 250014, China
2.Affiliated Hospital to Shandong University of Traditional Chinese Medicine, Jinan 250014, China
关键词:
特发性肺间质纤维化; 网络药理学; 信号通路; 分子对接; 冬虫夏草; 作用机制
Keywords:
idiopathic pulmonary fibrosis; network pharmacology; signaling pathway; molecular docking; mechanism of action
分类号:
R974
DOI:
10.12174/j.issn.2096-9600.2024.05.17
文献标志码:
A
摘要:
目的运用网络药理学和分子对接技术探究冬虫夏草治疗特发性肺间质纤维化（idiopathic pulmonary fibrosis，IPF）的作用机制。 方法通过中药系统药理学数据库与分析平台（traditional Chinese medicine systems pharmacology database and analysis platform，TCMSP）筛选出冬虫夏草的主要活性成分及其对应靶点；通过人类基因数据库（the human gene database，GeneCards）、在线人类孟德尔遗传数据库（online mendelian inheritance in man，OMIM）、DrugBank数据库检索获得IPF疾病相关靶点，取二者交集靶点作为冬虫夏草治疗IPF的关键作用靶点；将交集靶点上传至STRING数据库，构建冬虫夏草活性成分与IPF疾病的共同靶点蛋白-蛋白互作网络（protein-protein interactions，PPI），根据度值筛选出核心靶点；将交集靶点基因导入DAVID分析平台，进行基因本体（gene ontology，GO）、京都基因与基因组百科全书（kyoto encyclopedia of genes and genomes，KEGG）通路富集分析。 结果共获得冬虫夏草活性成分7个，作用于IPF的关键靶点84个；关键活性成分有乙酸亚油酯、花生四烯酸、胆固醇、β-谷甾醇，核心靶点有J原癌基因、过氧化物酶体增殖物激活受体γ、丝裂原活化蛋白激酶14等，GO和KEGG富集分析显示主要通路有TNF、VEGF、p53、cAMP、MARK、鞘脂等信号通路，涉及癌症、细胞凋亡、炎症反应等多个生物进程。冬虫夏草活性成分与靶点蛋白可以形成稳定的复合物。 结论冬虫夏草对IPF的治疗作用具有多成分、多靶点、多通路的特点。
Abstract:
ObjectiveTo investigate the mechanism of action of Dongchongxiacao (cordyceps) in the treatment of idiopathic pulmonary fibrosis (IPF) using network pharmacology and molecular docking technology. MethodsThe main active ingredients of Dongchongxiacao and their corresponding targets were screened by traditional Chinese medicine systems pharmacology database and analysis platform (TCMSP), and IPF-related targets were obtained by searching the human gene database (GeneCards), online mendelian inheritance in man (OMIM) database, and DrugBank database, and the intersection of the two targets was taken as the key target of the medicine in the treatment of IPF. The intersecting targets were uploaded to String database to construct a protein-protein interactions (PPI) network of active ingredients of the medicine and IPF, and the core targets were screened out according to the degree value. The intersecting target genes were imported into DAVID analysis platform for gene ontology (GO), Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analysis. ResultsA total of seven active ingredients of the medicine were obtained, and 84 key targets acting on IPF. The key active ingredients were linoleyl acetate, arachidonic acid, cholesterol, β-sitosterol, and the core targets were J proto-oncogene (JUN), peroxisome proliferator-activated receptor γ (PPARG), mitogen-activated protein kinase 14 (MAPK14), etc. The GO and KEGG enrichment analyses showed that the main pathways were TNF, VEGF, p53, cAMP, MARK, sphingolipid and other signaling pathways, involving in multiple biological processes such as cancer, apoptosis, and inflammatory response. Active ingredients and target proteins of the medicine can form stable complexes. ConclusionThe therapeutic effects of the medicine on IPF is characterized by multi-components, multi-targets and multi-pathways.

相似文献/References:

[1]樊茂蓉,徐凤芹△,王冰,等.补虚通痹方治疗特发性肺间质纤维化疗效观察[J].西部中医药,2019,32(05):77.
　FAN Maorong,XU Fengqin,et al.Observation on Clinical Effects of BuXu TongBi Prescriptions in the Treatment for Idiopathic Pulmonary Fibrosis[J].Western Journal of Traditional Chinese Medicine,2019,32(05):77.
[2]田琳,毕胜男,陈梦竹,等.基于网络药理学探索血府逐瘀汤治疗非小细胞肺癌的作用机制[J].西部中医药,2022,35(01):21.[doi:10.12174/j.issn.2096-9600.2022.01.05]
　TIAN Lin,BI Shengnan,CHEN Mengzhu,et al.Research on the Mechanism of Xuefu Zhuyu Decoction in the Treatment of NSCLC Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(05):21.[doi:10.12174/j.issn.2096-9600.2022.01.05]
[3]吴春凤,黄艳霞,郑景辉.基于网络药理学分析荆芥—防风药对的分子作用机制[J].西部中医药,2022,35(02):74.[doi:10.12174/j.issn.2096-9600.2022.02.18]
　WU Chunfeng,HUANG Yanxia,ZHENG Jinghui.Molecular Mechanism of Couplet Medicinals Jingjie‐Fangfeng Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(05):74.[doi:10.12174/j.issn.2096-9600.2022.02.18]
[4]陶鑫,薛中峰,覃骊兰.基于网络药理学的过敏煎治疗过敏性哮喘分子机制研究[J].西部中医药,2022,35(03):27.[doi:10.12174/j.issn.2096-9600.2022.03.07]
　TAO Xin,XUE Zhongfeng,QIN Lilan.Study on the Molecular Mechanism of Guomin Jian in the Treatment of Allergic Asthma Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(05):27.[doi:10.12174/j.issn.2096-9600.2022.03.07]
[5]黄康勤.基于网络药理学预测穿心莲内酯抗呼吸道感染的分子作用机制[J].西部中医药,2022,35(03):33.[doi:10.12174/j.issn.2096-9600.2022.03.08]
　HUANG Kangqin.Molecular Mechanism of Andrographolide against Respiratory Tract Infection Predicted by Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(05):33.[doi:10.12174/j.issn.2096-9600.2022.03.08]
[6]石威,张俊忠,解鹏超,等.基于网络药理学和分子对接探析淫羊藿-牛膝药对治疗股骨头坏死的作用机制[J].西部中医药,2022,35(04):35.[doi:10.12174/j.issn.2096-9600.2022.04.09]
　SHI Wei,ZHANG Junzhong,XIE Pengchao,et al.Study on the Mechanism of Yinyanghuo-Niuxi Drug Pair in Treating Femoral Head Necrosis Based on Network Pharmacology and Molecular Docking[J].Western Journal of Traditional Chinese Medicine,2022,35(05):35.[doi:10.12174/j.issn.2096-9600.2022.04.09]
[7]刘卓超,黄小靖,曾志聪.黄连生物碱改善心力衰竭的网络药理学机制研究[J].西部中医药,2022,35(04):42.[doi:10.12174/j.issn.2096-9600.2022.04.10]
　LIU Zhuochao,HUANG Xiaojing,ZENG Zhicong.Study on the Mechanism of Coptis Alkaloid in the Treatment of Heart Failure Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(05):42.[doi:10.12174/j.issn.2096-9600.2022.04.10]
[8]张维芯,周青,戴国梁,等.基于SARS-CoV-2关键蛋白ACE2探索“葛根-柴胡”治疗COVID-19的潜在机制[J].西部中医药,2022,35(05):1.[doi:10.12174/j.issn.2096-9600.2022.05.01]
　ZHANG Weixin,ZHOU Qing,DAI Guoliang,et al.The Potential Mechanism of “Gegen-Chaihu” in the Treatment of COVID-19 Based on SARS-CoV-2 Target Protein ACE2[J].Western Journal of Traditional Chinese Medicine,2022,35(05):1.[doi:10.12174/j.issn.2096-9600.2022.05.01]
[9]林鑫,刘阳,陈林伟,等.基于网络药理学探讨气血双补方抗慢性心力衰竭的作用机制[J].西部中医药,2022,35(06):29.[doi:10.12174/j.issn.2096-9600.2022.06.08]
　LIN Xin,LIU Yang,CHEN Linwei,et al.Study on the Mechanism of Qixue Shuangbu Prescription in Treating Chronic Heart Failure Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(05):29.[doi:10.12174/j.issn.2096-9600.2022.06.08]
[10]潘威.基于网络药理学探讨大黄治疗溃疡性结肠炎的机制[J].西部中医药,2022,35(06):80.[doi:10.12174/j.issn.2096-9600.2022.06.21]
　PAN Wei.The Mechanism of Dahuang in Treating Ulcerative Colitis Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(05):80.[doi:10.12174/j.issn.2096-9600.2022.06.21]

备注/Memo

备注/Memo:
周思琪（1996—），女，硕士学位，医师。研究方向：中医内科肺病的研究。国家自然科学基金应急管理项目（81641190）； 山东省自然科学基金面上项目（ZR2020MH351）；山东省医药卫生科技发展计划项目（2015WS0139）。
更新日期/Last Update: 2024-05-15